Nitric oxide pathway activation BPC-157 stimulates endothelial nitric oxide synthase (eNOS), improving vascular function and blood flow to reproductive tissues, including uterine and ovarian vasculature
Your protocol will be designed to your case, with follow-up appointments to monitor response and adjust dosing
Safety and side effects There is no safety file for MitoPrime as a combined product, so the risk picture is assembled from the parts, and it is thin for all three in humans
Research Use Only Important Compliance Notice This product is supplied exclusively for scientific, laboratory, and research purposes
S., Bjork, J
A study conducted in 2016 thus came to the following conclusion: If we had restricted the treatment of symptomatic patients to patients with both low serum levels and elevated metabolite levels, 63% of patients who responded well to the therapy would not have received treatment [] Only 16% of patients with good clinical improvement from vitamin B12 therapy had low serum levels and 54% of patients with good clinical improvement from vitamin B12 therapy had serum levels higher than 300 pg/mL. Some experts thus advise high-dose B12 treatment to treat all known nervous symptoms associated with B12 deficiency